-
New England Journal of Medicine publishes COVID-19 treatment trial results
worldpharmanews
January 18, 2021
A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results ...
-
Verona completes enrolment in pilot study of potential COVID-19 inhaler
pharmatimes
January 18, 2021
UK-headquartered Verona Pharma has completed enrolment in its pilot study evaluating the efficacy of ensifentrine delivered via pressurised metered-dose inhaler (pMDI) formulation in patients hospitalised with COVID-19.
-
Covishield to dominate overall COVID-19 vaccination drive in India: GlobalData
expresspharma
January 18, 2021
SII has taken the lead in supplying orders for the Indian government through 11 million doses ordered of Covishield versus 5.5 million doses of Covaxin.
-
Jubilant Therapeutics, The Wistar Institute to collaborate on COVID-19 research
expresspharma
January 18, 2021
To evaluate the activity of novel PAD4 inhibitors to reduce clinical severity of COVID-19.
-
India begins roll out of largest COVID-19 vaccination program
expresspharma
January 18, 2021
Made-in-India vaccines have been approved for emergency use only after the scientists and experts were fully convinced about their safety and efficacy: PM.
-
COVID-19 antibody therapy shows promise in Phase II/III trial
europeanpharmaceuticalreview
January 15, 2021
CT-P59, a monoclonal antibody therapy for COVID-19, was found to be particularly effective at reducing recovery times in moderate COVID-19 patients aged 50 plus.
-
UK could “become the world’s foremost nation for drug security,” says FarmaTrust
europeanpharmaceuticalreview
January 15, 2021
The global medical authentication provider is urging the government to secure the UK’s medicines supply by modernising the system with blockchain technologies.
-
NHS England selects supermarket Asda to operate COVID-19 vaccination centre
pharmatimes
January 15, 2021
NHS England has selected supermarket Asda to operate a COVID-19 vaccination centre from an in-store pharmacy based in Birmingham, UK.
-
DalCor Announces Launch of Dalcetrapib Clinical Trial for COVID-19
americanpharmaceuticalreview
January 15, 2021
DalCor announced the initiation of dal-COVID, a Phase 2 proof-of-concept study for dalcetrapib as a potential oral anti-viral treatment for COVID-19.
-
Microsoft, Cigna, Oracle partner for digital records of COVID-19 vaccination
expresspharma
January 15, 2021
The project, called Vaccination Credential Initiative, aims to help people get encrypted digital copies of their immunisation records stored in a digital wallet of their choice.